Dinactin: A New Antitumor Antibiotic with Cell Cycle Progression and Cancer Stemness Inhibiting Activities in Lung Cancer

15 Sep 2023
0
0

Dinactin: A New Antitumor Antibiotic with Cell Cycle Progression and Cancer Stemness Inhibiting Activities in Lung Cancer

Rawangkan A, Wongsirisin P, Pook-In G, Siriphap A, Yosboonruang A, Kiddee A, Chuerduangphui J, Reukngam N, Duangjai A, Saokaew S, Praphasawat R

Antibiotics. 2022;11(12):1845.

Tags

Share this

Related Posts

Fako, V., Martin, S. P., Pomyen, Y., Budhu, A., Chaisaingmongkol, J., Franck, S., . . . Wang, X. W. (2019). Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization. Int J Biol Sci, 15(12), 2654-2663. doi:10.7150/ijbs.39534
03 Oct 2019
0

Fako, V., Martin, S. P., Pomyen, Y., Budhu, A., Chaisaingmongkol, J., Franck, S., . . . Wang, X. W. (2019). Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization. Int J Biol Sci, 15(12), 2654-2663. doi:10.7150/ijbs.39534

Fako, V., Martin, S. P., Pomyen, Y., Budhu, A., Chaisaingmongkol, J., Franck, S., . . . Wang, X. W. (2019). Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization. Int J Biol Sci, 15(12), 2654-2663. doi:10.7150/ijbs.39534
View More

Recent Posts